Trial · NCT02646566
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Complete Response (Success of Initial PONV Treatment) | APD421 5mg | 80 | Participants | ||
| Number of Participants With Complete Response (Success of Initial PONV Treatment) | APD421 10mg | 96 | Participants | ||
| Number of Participants With Complete Response (Success of Initial PONV Treatment) | Placebo | 67 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | APD421 5mg | 134 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | APD421 10mg | 160 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | Placebo | 116 | Participants | ||
| Number of Participants With Complete Response 0-4 Hrs | APD421 5mg | 105 | Participants | ||
| Number of Participants With Complete Response 0-4 Hrs | APD421 10mg | 136 | Participants | ||
| Number of Participants With Complete Response 0-4 Hrs | Placebo | 87 | Participants | ||
| Number of Participants With Complete Response 0-6 Hrs | APD421 5mg | 99 | Participants | ||
| Number of Participants With Complete Response 0-6 Hrs | APD421 10mg | 121 | Participants | ||
| Number of Participants With Complete Response 0-6 Hrs | Placebo | 77 | Participants | ||
| Time to Treatment Failure | APD421 5mg | 188 | Inter-Quartile Range 43 to NA | minutes | |
| Time to Treatment Failure | APD421 10mg | 443 | Inter-Quartile Range 70 to NA | minutes | |
| Time to Treatment Failure | Placebo | 120 | Inter-Quartile Range 35 to NA | minutes | |
| Number of Patients With Incidence of Emesis | APD421 5mg | 43 | Participants | ||
| Number of Patients With Incidence of Emesis | APD421 10mg | 36 | Participants | ||
| Number of Patients With Incidence of Emesis | Placebo | 67 | Participants | ||
| Number of Patients Receiving Rescue Medication | APD421 5mg | 155 | Participants | ||
| Number of Patients Receiving Rescue Medication | APD421 10mg | 127 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02646566/results